NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Recro Pharma, Inc. (“Recro” or the “Company”) (NASDAQ:REPH) and certain of its officers. The class action, filed in United States …
Go to Source